Kodiak Sciences (KOD)
Kodiak Sciences on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances).
9.4M
Short interest
settlement 2026-09-30
1.8
Days to cover
-16.1 days vs prior
68.7%
Short share of volume
2026-10-09
300
Fails to deliver
settlement 2026-09-01
Thu 12 Nov
Next earnings
estimated date
$157.0M
Insider flow, 90 days
82 buys, 0 sells
As of 2026-10-09.
Short interest
FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in KOD is 9,376,012 shares, down 1,404,914 shares over the last month. Over the last 48 readings it ranged from 1,299,760 shares (31 October 2024) to 10,780,926 shares (31 August 2026). At the reported average volume of 5.2M shares a day that is 1.8 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/kod" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 9,376,012 | -12.2% | 5,205,761 | 1.80 |
| 2026-09-15 | 10,672,646 | -1.0% | 597,322 | 17.87 |
| 2026-08-31 | 10,780,926 | +4.6% | 584,274 | 18.45 |
| 2026-08-14 | 10,303,453 | +0.7% | 589,066 | 17.49 |
| 2026-07-31 | 10,229,369 | -1.8% | 496,379 | 20.61 |
| 2026-07-15 | 10,415,363 | -2.0% | 759,297 | 13.72 |
| 2026-06-30 | 10,628,588 | +1.4% | 1,033,904 | 10.28 |
| 2026-06-15 | 10,476,999 | +1.5% | 767,656 | 13.65 |
| 2026-05-29 | 10,320,428 | +1.1% | 600,768 | 17.18 |
| 2026-05-15 | 10,204,884 | -0.4% | 645,893 | 15.80 |
| 2026-04-30 | 10,247,730 | -0.7% | 587,353 | 17.45 |
| 2026-04-15 | 10,321,523 | +4.7% | 1,206,088 | 8.56 |
| 2026-03-31 | 9,854,423 | +39.8% | 2,419,047 | 4.07 |
| 2026-03-13 | 7,046,846 | -0.0% | 475,902 | 14.81 |
| 2026-02-27 | 7,049,989 | +2.5% | 686,585 | 10.27 |
| 2026-02-13 | 6,879,658 | -6.0% | 607,545 | 11.32 |
| 2026-01-30 | 7,319,045 | +2.7% | 685,756 | 10.67 |
| 2026-01-15 | 7,129,404 | +13.4% | 831,181 | 8.58 |
| 2025-12-31 | 6,287,793 | +34.5% | 1,390,153 | 4.52 |
| 2025-12-15 | 4,674,452 | -3.1% | 615,506 | 7.59 |
| 2025-11-28 | 4,824,586 | +7.1% | 821,783 | 5.87 |
| 2025-11-14 | 4,506,500 | +5.3% | 686,409 | 6.57 |
| 2025-10-31 | 4,278,753 | +12.7% | 1,136,956 | 3.76 |
| 2025-10-15 | 3,795,365 | -0.5% | 683,145 | 5.56 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 9 October 2026, the short share of KOD volume is 68.7%, up 9.8 points over the last five sessions. Over the last 30 readings it ranged from 39.8% (7 October 2026) to 77.0% (25 September 2026). The latest reading is 10.8 points above the 30-session average of 57.8%, on 704K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-09 | 483K | 704K | 68.7% | 0 |
| 2026-10-08 | 339K | 671K | 50.5% | 60 |
| 2026-10-07 | 192K | 482K | 39.8% | 42 |
| 2026-10-06 | 340K | 677K | 50.3% | 134 |
| 2026-10-05 | 847K | 1.4M | 61.5% | 761 |
| 2026-10-02 | 795K | 1.3M | 58.9% | 127 |
| 2026-10-01 | 973K | 1.7M | 58.4% | 0 |
| 2026-09-30 | 1.6M | 2.4M | 65.8% | 32,518 |
| 2026-09-29 | 2.1M | 3.2M | 64.8% | 45,881 |
| 2026-09-28 | 12.1M | 19.8M | 61.2% | 156,081 |
| 2026-09-25 | 658K | 855K | 77.0% | 341 |
| 2026-09-24 | 347K | 539K | 64.5% | 0 |
| 2026-09-23 | 233K | 475K | 48.9% | 25 |
| 2026-09-22 | 260K | 530K | 49.0% | 0 |
| 2026-09-21 | 156K | 230K | 67.7% | 0 |
| 2026-09-18 | 209K | 311K | 67.2% | 767 |
| 2026-09-17 | 217K | 322K | 67.5% | 1,319 |
| 2026-09-16 | 120K | 225K | 53.2% | 25 |
| 2026-09-15 | 173K | 290K | 59.8% | 0 |
| 2026-09-14 | 108K | 171K | 63.4% | 1,008 |
| 2026-09-11 | 168K | 274K | 61.5% | 5 |
| 2026-09-10 | 163K | 293K | 55.6% | 1,943 |
| 2026-09-09 | 106K | 197K | 53.9% | 2 |
| 2026-09-08 | 162K | 255K | 63.7% | 1,809 |
| 2026-09-04 | 125K | 272K | 45.8% | 301 |
| 2026-09-03 | 85K | 165K | 51.6% | 0 |
| 2026-09-02 | 100K | 197K | 50.8% | 0 |
| 2026-09-01 | 70K | 130K | 53.8% | 364 |
| 2026-08-31 | 214K | 492K | 43.5% | 100 |
| 2026-08-28 | 56K | 97K | 57.2% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 1 September 2026, the fails-to-deliver balance in KOD is 300 shares, up 298 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (18 June 2026) to 52,048 shares (30 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-01 | 300 | $37.35 | $11K |
| 2026-08-28 | 2 | $39.12 | $78 |
| 2026-08-20 | 4,900 | $40.07 | $196K |
| 2026-08-17 | 35 | $41.35 | $1K |
| 2026-08-04 | 363 | $39.83 | $14K |
| 2026-07-30 | 3 | $40.01 | $120 |
| 2026-07-21 | 1 | $40.87 | $41 |
| 2026-07-20 | 502 | $42.64 | $21K |
| 2026-07-16 | 85 | $42.42 | $4K |
| 2026-07-06 | 2,521 | $38.54 | $97K |
| 2026-06-30 | 52,048 | $37.74 | $2.0M |
| 2026-06-25 | 1,433 | $36.00 | $52K |
| 2026-06-24 | 14,364 | $37.05 | $532K |
| 2026-06-18 | 1 | $35.71 | $36 |
| 2026-06-15 | 141 | $34.06 | $5K |
| 2026-06-08 | 510 | $31.05 | $16K |
| 2026-05-20 | 21,418 | $34.42 | $737K |
| 2026-05-19 | 85 | $35.02 | $3K |
| 2026-05-07 | 10 | $45.89 | $459 |
| 2026-04-20 | 1,970 | $44.90 | $88K |
| 2026-04-14 | 269 | $41.95 | $11K |
| 2026-04-02 | 411 | $42.81 | $18K |
| 2026-03-27 | 3,395 | $39.76 | $135K |
| 2026-03-24 | 10,380 | $22.24 | $231K |
| 2026-03-23 | 824 | $22.25 | $18K |
| 2026-03-06 | 4,149 | $25.16 | $104K |
| 2026-03-02 | 347 | $26.80 | $9K |
| 2026-02-25 | 2,449 | $27.98 | $69K |
| 2026-02-23 | 1,920 | $25.28 | $49K |
| 2026-02-20 | 1,025 | $26.67 | $27K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at KOD reported 82 open-market buys worth $157.0M in the last 90 days and no open-market sells. Latest filing: BAKER BROS. ADVISORS LP (Director, 10% owner) on 2026-09-29.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-29 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 1K | $85.89 | $122K | 20.2M |
| 2026-09-29 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 84 | $85.89 | $7K | 1.7M |
| 2026-09-29 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 20K | $85.40 | $1.7M | 20.2M |
| 2026-09-29 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 1K | $85.40 | $102K | 1.7M |
| 2026-09-29 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 10K | $84.24 | $875K | 20.2M |
| 2026-09-29 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 619 | $84.24 | $52K | 1.7M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 197K | $89.86 | $17.7M | 20.2M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 12K | $89.86 | $1.1M | 1.7M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 83K | $89.60 | $7.4M | 20.0M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 5K | $89.60 | $442K | 1.7M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 108K | $88.65 | $9.6M | 19.9M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 6K | $88.65 | $570K | 1.7M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 99K | $88.57 | $8.7M | 19.8M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 6K | $88.57 | $521K | 1.6M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 75K | $87.51 | $6.6M | 19.7M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 4K | $87.51 | $392K | 1.6M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 64K | $86.94 | $5.5M | 19.6M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 4K | $86.94 | $330K | 1.6M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 16K | $86.81 | $1.4M | 19.5M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 957 | $86.81 | $83K | 1.6M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 3K | $86.72 | $270K | 19.5M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 186 | $86.72 | $16K | 1.6M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 39K | $85.97 | $3.3M | 19.5M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 2K | $85.97 | $200K | 1.6M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 110K | $84.85 | $9.3M | 19.5M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 7K | $84.85 | $556K | 1.6M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 124K | $83.95 | $10.4M | 19.4M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 7K | $83.95 | $620K | 1.6M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 20K | $83.16 | $1.6M | 19.2M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 1K | $83.16 | $97K | 1.6M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 2K | $82.68 | $140K | 19.2M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 101 | $82.68 | $8K | 1.6M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 651 | $81.92 | $53K | 19.2M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 39 | $81.92 | $3K | 1.6M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 28K | $81.82 | $2.3M | 19.2M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 2K | $81.82 | $137K | 1.6M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 17K | $81.31 | $1.4M | 19.2M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 1K | $81.31 | $85K | 1.6M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 6K | $81.20 | $459K | 19.2M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 338 | $81.20 | $27K | 1.6M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 17K | $81.02 | $1.4M | 19.2M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 1K | $81.02 | $83K | 1.6M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 1K | $80.52 | $83K | 19.2M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 61 | $80.52 | $5K | 1.6M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 7K | $80.23 | $544K | 19.2M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 404 | $80.23 | $32K | 1.6M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 15K | $79.71 | $1.2M | 19.1M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 884 | $79.71 | $70K | 1.6M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 283 | $79.63 | $23K | 19.1M |
| 2026-09-28 | BAKER BROS. ADVISORS LP | Director, 10% owner | Buy | 17 | $79.63 | $1K | 1.6M |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON2 Form 144 notices on file for KOD worth $2.3M at the prices reported; 0 in the last 90 days worth $0. Latest: JOHN BORGESON filed on 2026-06-04 to sell 30,000 shares ($1.0M) from 2026-06-04.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-06-04 | JOHN BORGESONOfficer | 30K | $1.0M | 0.048% | 2026-06-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-02 | JOHN BORGESONOfficer | 30K | $1.3M | 0.049% | 2026-04-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON9 holders report 5% or more of KOD in their latest filing, 4 on Schedule 13D (active intent). The largest reported stake is Julian C. Baker at 35.0% of the class (22,049,297 shares), filed 2026-09-30 for an event on 2026-09-28.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-09-30 | 13D/Ano. 12 | Julian C. Bakerindividual, parent holding company | 22.0M | 35.0% | 2026-09-28 |
| 2026-09-30 | 13D/Ano. 12 | Felix J. Bakerindividual, parent holding company | 22.0M | 35.0% | 2026-09-28 |
| 2026-09-30 | 13D/Ano. 12 | Baker Bros. Advisors (GP) LLCparent holding company, other entity | 22.0M | 35.0% | 2026-09-28 |
| 2026-09-30 | 13D/Ano. 12 | Baker Bros. Advisors LPinvestment adviser, partnership | 22.0M | 35.0% | 2026-09-28 |
| 2026-08-14 | 13G | T. Rowe Price Associates, Inc.investment adviser | 3.2M | 5.2% | 2026-06-30 |
| 2026-05-15 | 13G | Alex Silversteinparent holding company, individual | 3.5M | 5.7% | 2026-03-31 |
| 2026-05-15 | 13G | Sirenia Capital Management LPinvestment adviser, partnership | 3.5M | 5.7% | 2026-03-31 |
| 2026-04-27 | 13G | BlackRock, Inc.parent holding company | 3.3M | 5.3% | 2026-03-31 |
| 2026-04-02 | 13G | POINT72 CAPITAL ADVISORS, INC.corporation | 610K | 1.0% | 2026-03-26 |
| 2026-04-02 | 13G | POINT72 ASSET MANAGEMENT, L.P.partnership | 610K | 1.0% | 2026-03-26 |
| 2026-04-02 | 13G | STEVEN A. COHENindividual | 610K | 1.0% | 2026-03-26 |
| 2026-02-17 | 13G/Ano. 7 | D. VICTOR PERLROTH, M.D.individual | 6.5M | 9.9% | 2025-12-31 |
13F holders
Tracked managers holding KOD at their latest 13F. JSON7 of the 30 tracked managers held KOD at their latest 13F, $47.8M in total at quarter-end prices. Two Sigma Investments is the largest at $18.4M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 5 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Two Sigma Investments | 2026-06-30 | 473K | $18.4M | 0.01% | +374K |
| D. E. Shaw & Co. | 2026-06-30 | 211K | $8.2M | 0.00% | -19K |
| Renaissance Technologies | 2026-06-30 | 189K | $7.4M | 0.01% | -105K |
| Citadel Advisors | 2026-06-30 | 158K | $6.1M | 0.00% | -713K |
| Point72 Asset Management | 2026-06-30 | 98K | $3.8M | 0.00% | -362K |
| AQR Capital Management | 2026-06-30 | 68K | $2.6M | 0.00% | -18K |
| Millennium Management | 2026-06-30 | 31K | $1.2M | 0.00% | +17K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn FY 2025 it generated -$136.0M of operating cash flow.
- Cash
- $125.9M
- Equity
- $61.1M
- Total assets
- $256.8M
- Shares outstanding
- 62,849,457
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | n/a | -$65.6M | n/a | -1.05 |
| Q1 FY 2026 | 2026-03-31 | n/a | -$58.2M | n/a | -0.94 |
| Q4 FY 2025derived | 2025-12-31 | n/a | -$56.7M | n/a | n/a |
| Q3 FY 2025 | 2025-09-30 | n/a | -$61.5M | n/a | -1.16 |
| Q2 FY 2025 | 2025-06-30 | n/a | -$54.3M | n/a | -1.03 |
| Q1 FY 2025 | 2025-03-31 | n/a | -$57.5M | n/a | -1.09 |
| Q4 FY 2024derived | 2024-12-31 | n/a | -$44.1M | n/a | n/a |
| Q3 FY 2024 | 2024-09-30 | n/a | -$43.9M | n/a | -0.84 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | n/a | -$230.0M | -$136.0M | $506K | n/a | n/a |
| FY 2024 | 2024-12-31 | n/a | -$176.2M | -$117.3M | $375K | n/a | n/a |
| FY 2023 | 2023-12-31 | n/a | -$260.5M | -$154.2M | $41.4M | n/a | n/a |
| FY 2022 | 2022-12-31 | n/a | -$333.8M | -$206.5M | $37.0M | n/a | n/a |
| FY 2021 | 2021-12-31 | n/a | -$267.0M | -$182.3M | $17.0M | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-08-06 from the cover page.
What this page is
Kodiak Sciences in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Kodiak Sciences (KOD), SEC CIK 1468748, listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances). The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-01.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-06-04.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-09-30.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-13.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-29.JSON and CSV
- Company record
- EDGAR filing index for CIK 1468748Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as biological products, (no diagnostic substances)
- MRNAModerna
- TWSTTwist Bioscience
- ADPTAdaptive Biotechnologies
- NVAXNovavax
- RXRXRecursion Pharmaceuticals
- DNAGinkgo Bioworks Holdings
- PCVXVaxcyte
- NBIXNeurocrine Biosciences
- VIRVir Biotechnology
- EXELExelixis
- RVMDRevolution Medicines
- GILDGilead Sciences
- HALOHalozyme Therapeutics
- KYMRKymera Therapeutics
- AMGNAmgen
- KRYSKrystal Biotech
- RGENRepligen
- VCELVericel
- BIIBBiogen
- CRSPCRISPR Therapeutics
- DNLIDenali Therapeutics
- BDTXBlack Diamond Therapeutics
- TECHBio-Techne
- BEAMBeam Therapeutics
Datasets
Frequently Asked Questions
How much of KOD is sold short?
What is KOD's daily short volume?
Does KOD have fails to deliver?
Are KOD insiders buying or selling?
Have KOD insiders filed to sell?
Who owns 5% or more of KOD?
What did KOD report last quarter?
Which tracked 13F managers own KOD?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.